Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
That’s been the question floating around ResMed's (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea ...
Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.
Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in ...
Orders accelerated, margins expanded, and cash flow held up despite tariffs and the long shadow of Respironics.
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in comparable sales and a 160-basis-point improvement in adjusted EBITA margin to ...
Amsterdam, February 10, 2026Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in ...
SINGAPORE: Total employment growth in Singapore was stronger in 2025 than it was in 2024, with unemployment and retrenchments remaining low and stable, according to advance labour market figures for ...